[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fzelA4miyA1T4PXALJ2Mz1hai6krH-Pl6jAc_u7VTmIY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":31,"phaseBuckets":47,"rows":54},"Brugmann University Hospital",[4],117,false,10,5,52361,93,[13,15,18,20,23,25,27,29],{"name":14,"count":9},"Sarcopenia",{"name":16,"count":17},"Covid19",4,{"name":19,"count":17},"Sickle Cell Disease",{"name":21,"count":22},"Pediatric Cardiac Surgery",3,{"name":24,"count":22},"Surgery",{"name":26,"count":22},"Cardiac Surgery",{"name":28,"count":22},"Multiple Sclerosis",{"name":30,"count":22},"Breast Cancer",[32,37,42],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT05831345","Intraoperative Methadone for the Prevention of Postoperative Pain","2025-12","Methadone Hydrochloride",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT06160232","Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder","2025-12-15","Psilocybin",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT05272202","Investigation of Cerebral Motor Activity Modulations Following Median Nerve Stimulation During General Anaesthesia","2026-12-31","Propofol",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,80,98,121,139,187,213,231,256,274,292,320,338,364,392,410,434,460,485,503,528,552,578,596,623,641,667,685,709,733,760,784,809],{"intervention":36,"totalTrials":56,"cells":57},1,{"EARLY_PHASE1":58,"PHASE1":61,"PHASE2":63,"PHASE3":65,"PHASE4":76,"NA":78},{"trials":59,"activeCount":60},[],0,{"trials":62,"activeCount":60},[],{"trials":64,"activeCount":60},[],{"trials":66,"activeCount":56,"soonestReadout":35},[67],{"nctId":33,"briefTitle":34,"status":68,"phases":69,"primaryCompletion":35,"completion":35,"start":70,"enrollment":71,"conditions":72,"interventions":74},"RECRUITING",[51],"2023-02-28",80,[73],"Orthopedic Surgery",[36,75],"Sufentanil Citrate",{"trials":77,"activeCount":60},[],{"trials":79,"activeCount":60},[],{"intervention":75,"totalTrials":56,"cells":81},{"EARLY_PHASE1":82,"PHASE1":84,"PHASE2":86,"PHASE3":88,"PHASE4":94,"NA":96},{"trials":83,"activeCount":60},[],{"trials":85,"activeCount":60},[],{"trials":87,"activeCount":60},[],{"trials":89,"activeCount":56,"soonestReadout":35},[90],{"nctId":33,"briefTitle":34,"status":68,"phases":91,"primaryCompletion":35,"completion":35,"start":70,"enrollment":71,"conditions":92,"interventions":93},[51],[73],[36,75],{"trials":95,"activeCount":60},[],{"trials":97,"activeCount":60},[],{"intervention":41,"totalTrials":56,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":115,"PHASE4":117,"NA":119},{"trials":101,"activeCount":60},[],{"trials":103,"activeCount":60},[],{"trials":105,"activeCount":56,"soonestReadout":40},[106],{"nctId":38,"briefTitle":39,"status":68,"phases":107,"primaryCompletion":40,"completion":108,"start":109,"enrollment":110,"conditions":111,"interventions":113},[50],"2026-06-15","2024-02-15",62,[112],"Severe Alcohol Use Disorder",[41,114],"Active placebo",{"trials":116,"activeCount":60},[],{"trials":118,"activeCount":60},[],{"trials":120,"activeCount":60},[],{"intervention":114,"totalTrials":56,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":133,"PHASE4":135,"NA":137},{"trials":124,"activeCount":60},[],{"trials":126,"activeCount":60},[],{"trials":128,"activeCount":56,"soonestReadout":40},[129],{"nctId":38,"briefTitle":39,"status":68,"phases":130,"primaryCompletion":40,"completion":108,"start":109,"enrollment":110,"conditions":131,"interventions":132},[50],[112],[41,114],{"trials":134,"activeCount":60},[],{"trials":136,"activeCount":60},[],{"trials":138,"activeCount":60},[],{"intervention":46,"totalTrials":22,"cells":140},{"EARLY_PHASE1":141,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":170,"NA":172},{"trials":142,"activeCount":56,"soonestReadout":45},[143],{"nctId":43,"briefTitle":44,"status":68,"phases":144,"primaryCompletion":45,"completion":45,"start":145,"enrollment":146,"conditions":147,"interventions":149},[48],"2023-01-15",30,[148],"Accidental Awareness During General Anesthesia",[46],{"trials":151,"activeCount":60},[],{"trials":153,"activeCount":60},[],{"trials":155,"activeCount":60},[156],{"nctId":157,"briefTitle":158,"status":159,"phases":160,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":168},"NCT05615025","Influence of Sevoflurane and Propofol on Maximum Muscular Strength, Speed of Contraction and Relaxation","COMPLETED",[51],"2023-06-30","2023-07-07","2023-01-20",48,[166,167],"Anesthesia, General","Neuromuscular Transmission Disorders",[169,46],"Sevoflurane",{"trials":171,"activeCount":60},[],{"trials":173,"activeCount":60},[174],{"nctId":175,"briefTitle":176,"status":159,"phases":177,"primaryCompletion":178,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":186},"NCT04455776","Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients",[],"2020-07-30","2020-07-03",99,[182,183,184,185],"Multiparametric Magnetic Resonance Imaging","Propofol Adverse Reaction","Sedation Complication","Anesthesia; Adverse Effect",[46],{"intervention":188,"totalTrials":56,"cells":189},"Manual titration of propofol",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":211},{"trials":191,"activeCount":60},[],{"trials":193,"activeCount":60},[],{"trials":195,"activeCount":60},[],{"trials":197,"activeCount":60},[],{"trials":199,"activeCount":60},[200],{"nctId":201,"briefTitle":202,"status":159,"phases":203,"primaryCompletion":204,"completion":204,"start":205,"enrollment":206,"conditions":207,"interventions":209},"NCT02314559","A Psychomotor Recuperation Study After Deep Sedation for Colonoscopy Between Target Controlled and Manual Titration of Propofol",[52],"2020-07-07","2015-02",164,[208],"Colonoscopy (Ambulatory Patients)",[188,210],"Target controlled infusion of propofol",{"trials":212,"activeCount":60},[],{"intervention":210,"totalTrials":56,"cells":214},{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":229},{"trials":216,"activeCount":60},[],{"trials":218,"activeCount":60},[],{"trials":220,"activeCount":60},[],{"trials":222,"activeCount":60},[],{"trials":224,"activeCount":60},[225],{"nctId":201,"briefTitle":202,"status":159,"phases":226,"primaryCompletion":204,"completion":204,"start":205,"enrollment":206,"conditions":227,"interventions":228},[52],[208],[188,210],{"trials":230,"activeCount":60},[],{"intervention":232,"totalTrials":56,"cells":233},"Plasmalyte",{"EARLY_PHASE1":234,"PHASE1":236,"PHASE2":238,"PHASE3":240,"PHASE4":242,"NA":254},{"trials":235,"activeCount":60},[],{"trials":237,"activeCount":60},[],{"trials":239,"activeCount":60},[],{"trials":241,"activeCount":60},[],{"trials":243,"activeCount":60},[244],{"nctId":245,"briefTitle":246,"status":159,"phases":247,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":252},"NCT02312999","Crystalloids or Colloids for Goal-directed Fluid Therapy With Closed-loop Assistance in Major Surgery",[52],"2017-12-21","2015-02-24",160,[24],[232,253],"Volulyte",{"trials":255,"activeCount":60},[],{"intervention":253,"totalTrials":56,"cells":257},{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":264,"PHASE4":266,"NA":272},{"trials":259,"activeCount":60},[],{"trials":261,"activeCount":60},[],{"trials":263,"activeCount":60},[],{"trials":265,"activeCount":60},[],{"trials":267,"activeCount":60},[268],{"nctId":245,"briefTitle":246,"status":159,"phases":269,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":270,"interventions":271},[52],[24],[232,253],{"trials":273,"activeCount":60},[],{"intervention":169,"totalTrials":56,"cells":275},{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":288,"NA":290},{"trials":277,"activeCount":60},[],{"trials":279,"activeCount":60},[],{"trials":281,"activeCount":60},[],{"trials":283,"activeCount":60},[284],{"nctId":157,"briefTitle":158,"status":159,"phases":285,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":286,"interventions":287},[51],[166,167],[169,46],{"trials":289,"activeCount":60},[],{"trials":291,"activeCount":60},[],{"intervention":293,"totalTrials":56,"cells":294},"Ephedrine",{"EARLY_PHASE1":295,"PHASE1":297,"PHASE2":299,"PHASE3":301,"PHASE4":316,"NA":318},{"trials":296,"activeCount":60},[],{"trials":298,"activeCount":60},[],{"trials":300,"activeCount":60},[],{"trials":302,"activeCount":60},[303],{"nctId":304,"briefTitle":305,"status":306,"phases":307,"primaryCompletion":308,"completion":309,"start":310,"enrollment":311,"conditions":312,"interventions":314},"NCT05497700","Comparative Efficacity of Ephedrine Versus Norepinephrine to Correct Anesthesia Induction Related Hypotension","UNKNOWN",[51],"2023-09-30","2023-10-30","2022-09-15",60,[313],"Hypotension on Induction",[293,315],"Norepinephrine",{"trials":317,"activeCount":60},[],{"trials":319,"activeCount":60},[],{"intervention":315,"totalTrials":56,"cells":321},{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":334,"NA":336},{"trials":323,"activeCount":60},[],{"trials":325,"activeCount":60},[],{"trials":327,"activeCount":60},[],{"trials":329,"activeCount":60},[330],{"nctId":304,"briefTitle":305,"status":306,"phases":331,"primaryCompletion":308,"completion":309,"start":310,"enrollment":311,"conditions":332,"interventions":333},[51],[313],[293,315],{"trials":335,"activeCount":60},[],{"trials":337,"activeCount":60},[],{"intervention":339,"totalTrials":56,"cells":340},"Sufentanyl\u002FLevobupivacaine",{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":360,"NA":362},{"trials":342,"activeCount":60},[],{"trials":344,"activeCount":60},[],{"trials":346,"activeCount":60},[],{"trials":348,"activeCount":60},[349],{"nctId":350,"briefTitle":351,"status":306,"phases":352,"primaryCompletion":161,"completion":353,"start":354,"enrollment":355,"conditions":356,"interventions":359},"NCT05196256","Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia.",[51],"2023-07-30","2022-06-30",90,[357,358],"Obstetric Pain","Analgesia",[339],{"trials":361,"activeCount":60},[],{"trials":363,"activeCount":60},[],{"intervention":365,"totalTrials":56,"cells":366},"Dexmedetomidine",{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":373,"PHASE4":388,"NA":390},{"trials":368,"activeCount":60},[],{"trials":370,"activeCount":60},[],{"trials":372,"activeCount":60},[],{"trials":374,"activeCount":60},[375],{"nctId":376,"briefTitle":377,"status":306,"phases":378,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":383,"interventions":387},"NCT05192629","Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging",[51],"2023-06-15","2023-07-31","2022-03-09",250,[384,385,386,365],"MRI","Pediatric Sedation","Midazolam",[365,386],{"trials":389,"activeCount":60},[],{"trials":391,"activeCount":60},[],{"intervention":386,"totalTrials":56,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":406,"NA":408},{"trials":395,"activeCount":60},[],{"trials":397,"activeCount":60},[],{"trials":399,"activeCount":60},[],{"trials":401,"activeCount":60},[402],{"nctId":376,"briefTitle":377,"status":306,"phases":403,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":404,"interventions":405},[51],[384,385,386,365],[365,386],{"trials":407,"activeCount":60},[],{"trials":409,"activeCount":60},[],{"intervention":411,"totalTrials":56,"cells":412},"Diprophos",{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":428,"PHASE4":430,"NA":432},{"trials":414,"activeCount":60},[],{"trials":416,"activeCount":60},[],{"trials":418,"activeCount":60},[419],{"nctId":420,"briefTitle":421,"status":159,"phases":422,"primaryCompletion":423,"completion":423,"start":424,"enrollment":311,"conditions":425,"interventions":427},"NCT02916940","Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.",[50],"2020-02-11","2016-11-16",[426],"Sprain",[411],{"trials":429,"activeCount":60},[],{"trials":431,"activeCount":60},[],{"trials":433,"activeCount":60},[],{"intervention":435,"totalTrials":56,"cells":436},"Lidocaine",{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":454,"PHASE4":456,"NA":458},{"trials":438,"activeCount":60},[],{"trials":440,"activeCount":60},[],{"trials":442,"activeCount":60},[443],{"nctId":444,"briefTitle":445,"status":446,"phases":447,"primaryCompletion":448,"completion":448,"start":449,"enrollment":60,"conditions":450,"interventions":453},"NCT02696720","A Trial of Lidocaine Patch for Lower Limb Amputation Pain","WITHDRAWN",[50],"2017-06-13","2016-05-13",[451,452],"Phantom Limb Pain (PLP)","Primary\u002FSecondary Scar Hyperalgesia",[435],{"trials":455,"activeCount":60},[],{"trials":457,"activeCount":60},[],{"trials":459,"activeCount":60},[],{"intervention":461,"totalTrials":56,"cells":462},"Chirocaine 0.07% + Sufentanil 0.3 mcg\u002Fml 10ml\u002Fh",{"EARLY_PHASE1":463,"PHASE1":465,"PHASE2":467,"PHASE3":479,"PHASE4":481,"NA":483},{"trials":464,"activeCount":60},[],{"trials":466,"activeCount":60},[],{"trials":468,"activeCount":60},[469],{"nctId":470,"briefTitle":471,"status":446,"phases":472,"primaryCompletion":473,"completion":473,"start":474,"enrollment":60,"conditions":475,"interventions":477},"NCT02705872","Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women",[50],"2018-03-20","2016-03-08",[476],"First Child Delivery With Epidural",[461,478],"Chirocaine 0.07% + Sufentanil 0.3 mcg\u002Fml 10ml each 60 minutes",{"trials":480,"activeCount":60},[],{"trials":482,"activeCount":60},[],{"trials":484,"activeCount":60},[],{"intervention":478,"totalTrials":56,"cells":486},{"EARLY_PHASE1":487,"PHASE1":489,"PHASE2":491,"PHASE3":497,"PHASE4":499,"NA":501},{"trials":488,"activeCount":60},[],{"trials":490,"activeCount":60},[],{"trials":492,"activeCount":60},[493],{"nctId":470,"briefTitle":471,"status":446,"phases":494,"primaryCompletion":473,"completion":473,"start":474,"enrollment":60,"conditions":495,"interventions":496},[50],[476],[461,478],{"trials":498,"activeCount":60},[],{"trials":500,"activeCount":60},[],{"trials":502,"activeCount":60},[],{"intervention":504,"totalTrials":56,"cells":505},"Cidofovir",{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":522,"PHASE4":524,"NA":526},{"trials":507,"activeCount":60},[],{"trials":509,"activeCount":60},[],{"trials":511,"activeCount":60},[512],{"nctId":513,"briefTitle":514,"status":159,"phases":515,"primaryCompletion":516,"completion":516,"start":517,"enrollment":518,"conditions":519,"interventions":521},"NCT02976987","A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w\u002Fw) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.",[50],"2016-04","2013-02",36,[520],"High Grade Cervical Epithelial Neoplasia (CIN2+)",[504],{"trials":523,"activeCount":60},[],{"trials":525,"activeCount":60},[],{"trials":527,"activeCount":60},[],{"intervention":529,"totalTrials":56,"cells":530},"Levobupivacaine",{"EARLY_PHASE1":531,"PHASE1":533,"PHASE2":535,"PHASE3":546,"PHASE4":548,"NA":550},{"trials":532,"activeCount":60},[],{"trials":534,"activeCount":60},[],{"trials":536,"activeCount":60},[537],{"nctId":538,"briefTitle":539,"status":446,"phases":540,"primaryCompletion":541,"completion":541,"start":542,"enrollment":60,"conditions":543,"interventions":545},"NCT02796547","Effect of Levobupivacaine Infiltration on the Post Partum Perineal Pain in Episiotomy, in Primiparous Women After Instrumental Delivery",[50],"2018-05-29","2016-07-14",[544],"Episiotomy",[529],{"trials":547,"activeCount":60},[],{"trials":549,"activeCount":60},[],{"trials":551,"activeCount":60},[],{"intervention":553,"totalTrials":56,"cells":554},"Tranexamic Acid",{"EARLY_PHASE1":555,"PHASE1":568,"PHASE2":570,"PHASE3":572,"PHASE4":574,"NA":576},{"trials":556,"activeCount":60},[557],{"nctId":558,"briefTitle":559,"status":159,"phases":560,"primaryCompletion":561,"completion":561,"start":562,"enrollment":563,"conditions":564,"interventions":566},"NCT02319915","Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.",[48],"2017-03-14","2015-02-18",14,[565],"Knee Prosthesis",[553,567],"Adrenalin",{"trials":569,"activeCount":60},[],{"trials":571,"activeCount":60},[],{"trials":573,"activeCount":60},[],{"trials":575,"activeCount":60},[],{"trials":577,"activeCount":60},[],{"intervention":567,"totalTrials":56,"cells":579},{"EARLY_PHASE1":580,"PHASE1":586,"PHASE2":588,"PHASE3":590,"PHASE4":592,"NA":594},{"trials":581,"activeCount":60},[582],{"nctId":558,"briefTitle":559,"status":159,"phases":583,"primaryCompletion":561,"completion":561,"start":562,"enrollment":563,"conditions":584,"interventions":585},[48],[565],[553,567],{"trials":587,"activeCount":60},[],{"trials":589,"activeCount":60},[],{"trials":591,"activeCount":60},[],{"trials":593,"activeCount":60},[],{"trials":595,"activeCount":60},[],{"intervention":597,"totalTrials":56,"cells":598},"adalimumab",{"EARLY_PHASE1":599,"PHASE1":613,"PHASE2":615,"PHASE3":617,"PHASE4":619,"NA":621},{"trials":600,"activeCount":60},[601],{"nctId":602,"briefTitle":603,"status":159,"phases":604,"primaryCompletion":605,"completion":606,"start":607,"enrollment":608,"conditions":609,"interventions":611},"NCT02252809","Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects",[48],"2009-04","2009-07","2008-11",51,[610],"Innate Immunity",[597,612],"methylprednisolone",{"trials":614,"activeCount":60},[],{"trials":616,"activeCount":60},[],{"trials":618,"activeCount":60},[],{"trials":620,"activeCount":60},[],{"trials":622,"activeCount":60},[],{"intervention":612,"totalTrials":56,"cells":624},{"EARLY_PHASE1":625,"PHASE1":631,"PHASE2":633,"PHASE3":635,"PHASE4":637,"NA":639},{"trials":626,"activeCount":60},[627],{"nctId":602,"briefTitle":603,"status":159,"phases":628,"primaryCompletion":605,"completion":606,"start":607,"enrollment":608,"conditions":629,"interventions":630},[48],[610],[597,612],{"trials":632,"activeCount":60},[],{"trials":634,"activeCount":60},[],{"trials":636,"activeCount":60},[],{"trials":638,"activeCount":60},[],{"trials":640,"activeCount":60},[],{"intervention":642,"totalTrials":56,"cells":643},"dinitrate isosorbide",{"EARLY_PHASE1":644,"PHASE1":646,"PHASE2":648,"PHASE3":650,"PHASE4":652,"NA":654},{"trials":645,"activeCount":60},[],{"trials":647,"activeCount":60},[],{"trials":649,"activeCount":60},[],{"trials":651,"activeCount":60},[],{"trials":653,"activeCount":60},[],{"trials":655,"activeCount":60},[656],{"nctId":657,"briefTitle":658,"status":159,"phases":659,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":663,"interventions":665},"NCT02258620","Prevention and Comparison of Different Forms of Administration of Nitrates in the Risk of Radial Spasm During Coronary Angiography.",[53],"2014-09","2013-06",442,[664],"Coronaropathy",[642,666],"nitroglycerine",{"intervention":666,"totalTrials":56,"cells":668},{"EARLY_PHASE1":669,"PHASE1":671,"PHASE2":673,"PHASE3":675,"PHASE4":677,"NA":679},{"trials":670,"activeCount":60},[],{"trials":672,"activeCount":60},[],{"trials":674,"activeCount":60},[],{"trials":676,"activeCount":60},[],{"trials":678,"activeCount":60},[],{"trials":680,"activeCount":60},[681],{"nctId":657,"briefTitle":658,"status":159,"phases":682,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":683,"interventions":684},[53],[664],[642,666],{"intervention":686,"totalTrials":56,"cells":687},"Geloplasma",{"EARLY_PHASE1":688,"PHASE1":690,"PHASE2":692,"PHASE3":694,"PHASE4":696,"NA":698},{"trials":689,"activeCount":60},[],{"trials":691,"activeCount":60},[],{"trials":693,"activeCount":60},[],{"trials":695,"activeCount":60},[],{"trials":697,"activeCount":60},[],{"trials":699,"activeCount":60},[700],{"nctId":701,"briefTitle":702,"status":159,"phases":703,"primaryCompletion":704,"completion":704,"start":705,"enrollment":71,"conditions":706,"interventions":708},"NCT02908256","Comparison of Intraoperative Volume Replacement Determined by the Plethysmograph Variability Index (PVI) With That Determined by the Delta PP in the Digestive, Gynecological, Urological, and Abdominal Surgery and Their Impact on the Length of Stay",[53],"2016-03","2011-04",[707],"Abdomino-pelvic Surgery",[686,686],{"intervention":710,"totalTrials":56,"cells":711},"dobu",{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":716,"PHASE3":718,"PHASE4":720,"NA":722},{"trials":713,"activeCount":60},[],{"trials":715,"activeCount":60},[],{"trials":717,"activeCount":60},[],{"trials":719,"activeCount":60},[],{"trials":721,"activeCount":60},[],{"trials":723,"activeCount":60},[724],{"nctId":725,"briefTitle":726,"status":159,"phases":727,"primaryCompletion":728,"completion":729,"start":730,"enrollment":382,"conditions":731,"interventions":732},"NCT04380181","Influence of Inotropic Choice on Morbidity and Mortality in Complex Pediatric Heart Surgery",[],"2020-06-05","2020-06-10","2020-05-11",[21],[710],{"intervention":734,"totalTrials":56,"cells":735},"Fluid balance",{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":737,"activeCount":60},[],{"trials":739,"activeCount":60},[],{"trials":741,"activeCount":60},[],{"trials":743,"activeCount":60},[],{"trials":745,"activeCount":60},[],{"trials":747,"activeCount":60},[748],{"nctId":749,"briefTitle":750,"status":159,"phases":751,"primaryCompletion":752,"completion":753,"start":754,"enrollment":755,"conditions":756,"interventions":759},"NCT05142046","Influence of Intraoperative Fluid Balance on the Incidence of Adverse Events in Pediatric Cardiac Surgery",[],"2022-04-30","2022-06-10","2022-03-01",1400,[757,24,758],"Congenital Heart Disease in Children","Fluid Overload",[734],{"intervention":761,"totalTrials":56,"cells":762},"Capsaïcine patch",{"EARLY_PHASE1":763,"PHASE1":765,"PHASE2":767,"PHASE3":769,"PHASE4":771,"NA":773},{"trials":764,"activeCount":60},[],{"trials":766,"activeCount":60},[],{"trials":768,"activeCount":60},[],{"trials":770,"activeCount":60},[],{"trials":772,"activeCount":60},[],{"trials":774,"activeCount":60},[775],{"nctId":776,"briefTitle":777,"status":306,"phases":778,"primaryCompletion":308,"completion":309,"start":779,"enrollment":780,"conditions":781,"interventions":783},"NCT05523934","Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome",[],"2022-09-16",50,[782],"Complex Regional Pain Syndromes",[761],{"intervention":785,"totalTrials":56,"cells":786},"p.Thr328Lys mutation detection",{"EARLY_PHASE1":787,"PHASE1":789,"PHASE2":791,"PHASE3":793,"PHASE4":795,"NA":797},{"trials":788,"activeCount":60},[],{"trials":790,"activeCount":60},[],{"trials":792,"activeCount":60},[],{"trials":794,"activeCount":60},[],{"trials":796,"activeCount":60},[],{"trials":798,"activeCount":60},[799],{"nctId":800,"briefTitle":801,"status":159,"phases":802,"primaryCompletion":803,"completion":803,"start":804,"enrollment":805,"conditions":806,"interventions":808},"NCT03917680","Evaluation of New Markers in Type 3 Angioedema",[53],"2019-10-08","2018-10-29",32,[807],"Angio Edema",[785],{"intervention":810,"totalTrials":56,"cells":811},"mirtazapine",{"EARLY_PHASE1":812,"PHASE1":814,"PHASE2":816,"PHASE3":818,"PHASE4":820,"NA":822},{"trials":813,"activeCount":60},[],{"trials":815,"activeCount":60},[],{"trials":817,"activeCount":60},[],{"trials":819,"activeCount":60},[],{"trials":821,"activeCount":60},[],{"trials":823,"activeCount":60},[824],{"nctId":825,"briefTitle":826,"status":159,"phases":827,"primaryCompletion":828,"completion":829,"start":830,"enrollment":831,"conditions":832,"interventions":837},"NCT01505504","Mirtazapine in Alzheimer-associated Weight Loss",[],"2011-11","2011-12","2004-01",22,[833,834,835,836],"Alzheimer's Disease","Weight Loss","Mixed Dementia","Dementia",[810]]